Citation:Tol J, Koopman M, Cats A, Rodenburg CJ, Creemers GJ, Schrama JG, et al 2009

From Cancer Guidelines Wiki

Citation


Tol J, Koopman M, Cats A, Rodenburg CJ, Creemers GJ, Schrama JG, et al. Chemotherapy, bevacizumab, and cetuximab in metastatic colorectal cancer. N Engl J Med 2009 Feb 5;360(6):563-72 Available from: http://www.ncbi.nlm.nih.gov/pubmed/19196673.



Critical appraisals

Critical appraisal linkClinical questionAssigned toStatus
Optimal molecular profilingDr Albert Chetcuti BTech(Biotech) Hons, PhDcompleted
Optimal molecular profilingBen Lee-Batescompleted

Compare quality appraisals for each clinical question

  • [[Clinical question:Molecular profiling of CRC|
    Invalid title «<span class="smw-format list-format "><span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:Molecular profiling of CRC</span></span></span>»
    ]] (compare critical appraisals)
  • [[Clinical question:Molecular profiling of CRC|
    Invalid title «<span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:Molecular profiling of CRC</span></span></span></span>»
    ]] (compare critical appraisals)

Cited by

  1. Management of synchronous primary colorectal cancer with unresectable metastatic disease
  2. Optimal molecular profiling